CA3305935A1 - Compositions et méthodes pour traiter des troubles douloureux - Google Patents

Compositions et méthodes pour traiter des troubles douloureux

Info

Publication number
CA3305935A1
CA3305935A1 CA3305935A CA3305935A CA3305935A1 CA 3305935 A1 CA3305935 A1 CA 3305935A1 CA 3305935 A CA3305935 A CA 3305935A CA 3305935 A CA3305935 A CA 3305935A CA 3305935 A1 CA3305935 A1 CA 3305935A1
Authority
CA
Canada
Prior art keywords
compositions
methods
treating pain
pain disorders
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3305935A
Other languages
English (en)
Inventor
Graham Beaton
Yury Miller
Soo-Ho Choi
Tony L. Yaksh
Original Assignee
Raft Pharmaceuticals Inc
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raft Pharmaceuticals Inc, University of California San Diego UCSD filed Critical Raft Pharmaceuticals Inc
Publication of CA3305935A1 publication Critical patent/CA3305935A1/fr
Pending legal-status Critical Current

Links

CA3305935A 2023-10-03 2024-10-03 Compositions et méthodes pour traiter des troubles douloureux Pending CA3305935A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63/587,608 2023-10-03

Publications (1)

Publication Number Publication Date
CA3305935A1 true CA3305935A1 (fr) 2025-04-10

Family

ID=

Similar Documents

Publication Publication Date Title
EP4210714A4 (fr) Compositions topiques et méthodes de traitement de la douleur
EP4352079A4 (fr) Compositions et méthodes pour traiter des troubles neurofibromatiques
EP4135661A4 (fr) Compositions et méthodes de traitement de troubles neurologiques
EP4138852A4 (fr) Compositions et procédés pour le traitement de la douleur
EP4175978A4 (fr) Compositions et méthodes pour traiter des maladies médiées par crp
CA3261972A1 (fr) Compositions et méthodes pour le traitement de troubles métaboliques
CA3305935A1 (fr) Compositions et méthodes pour traiter des troubles douloureux
EP4136072A4 (fr) Compositions et méthodes de traitement de la douleur et/ou de l'inflammation
AU2024374758A1 (en) Compositions and methods for treating skin disorders
CA3297601A1 (fr) Procédés et compositions pour le traitement de troubles associés à ctnnb1
HK40131011A (en) Methods and compositions for treating hsd-1-mediated disorders
CA3278656A1 (fr) Procédés et compositions pour traiter des troubles médiés par hsd-1
AU2022903123A0 (en) Compositions and methods for treating disorders
AU2024363527A1 (en) Compositions and methods for treating gastrointestinal-related diseases and disorders
CA3308877A1 (fr) Compositions et méthodes de traitement de maladies et de troubles gastro-intestinaux
CA3291315A1 (fr) Méthodes thérapeutiques et compositions de traitement des troubles du mouvement
HK40110376A (en) Compositions and methods for treating neurofibromatic disorders
AU2022901710A0 (en) Compositions and methods for treating neurological disorders
AU2022900640A0 (en) Compositions and methods for treating neurological disorders
CA3285901A1 (fr) Compositions de microbiote et méthodes de traitement de troubles
AU2023900704A0 (en) Microbiota Compositions and Methods for Treating Disorders
AU2021903256A0 (en) Compositions and methods for treating neurological disorders
IL326321A (en) Methods and compositions for treating CTNNB1-related disorders
IL321862A (en) Methods and compounds for treating disorders caused by HSD-1
CA3271202A1 (fr) Compositions et méthodes de traitement de troubles dégénératifs de la rétine